We are particularly happy, especially after our difficulties yesterday. You may have noticed sporadic posting, which was due to a burst pipe valve in the basement of the Pharmalot headquarters, a disruption assuaged only by our on-call Pharmalot maintenance crew. The problem has been solved, although we look forward to a respite. Nonetheless, there is much to do, especially as the American College of Cardiology conference kicks off and we prepare for a speaking engagement of our own. So grab that cup of stimulation and polish off the week with us…

Drug-Coated Stents No Riskier Than Others: Study (Dow Jones)

Some Biotechs Race To Develop Biosimilars (Bloomberg News)

J&J Foot Gel Poses Cancer Risk (Yahoo/Reuters)

Takeda Scraps Development Of Cholesterol Pill (Bloomberg News)

Wyeth And Trubion Halt Drug Study (The Seattle Post-Intelligencer)

Skye Pharma Seeks Compromise On Its Bonds (The Financial Times*)

* - subscription may be required